Winning pharma brands: Changing the rules of a market
Understanding the bigger questions that winning pharma brands ask to change the market and redefine the playing field. The global health emergency that we are...
Pf Webinars: Pharma and Integrated Care Systems – How to make your brand relevant
Pf is proud to announce a new FREE webinar series with Triducive. The first webinar, focuses on pharma and integrated care systems. In this...
Why are life science companies contracting market access activities?
Sathyanarayanan Krishnamurthy, Vice President – Regulatory Operations at Freyr Solutions looks at contracting out market access activities and how this frees up life sciences...
Mind the generation gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
The art of customer experience management (CXM)
Magnus Franzen explains why customer experience management is essential to delivering what your customers need. Customer experience management (CXM) is both a discipline and a philosophy.
“ACROSS...
The key to engaging healthcare professionals effectively
Hank Sczerba on how to understand healthcare professionals in order to target them more effectively
Tell me about yourself and what you do? I am Head...
Improve your sales insight using AI
Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...
The impact of Brexit on the regulatory and marketing landscape
Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...
HFMA’s Chris Calkin on how the money in the NHS system works
How does the money flow through the NHS? Here’s the inside intelligence.
The complicated structure of the NHS is often impenetrable, even to those who...
Latest articles
NICE recommendation for GSK’s ovarian cancer treatment
National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...
Victims of abuse given code word to ask pharmacists for help
Victims of domestic abuse will be able to access much needed support from thousands of pharmacies across the UK, in a new scheme backed...
Positive trial results for Eli Lilly’s Donanemab in Alzheimer’s
A positive Phase 2 Trial of Eli Lilly’s donanemab, an investigational antibody, has shown significant slowing of decline in a composite measure of cognition...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
JCVI updates priority list for COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
NICE recommendation for GSK’s ovarian cancer treatment
National Institute for Health and Care Excellence (NICE) has recommended GSK’s ZEJULA®▼ (niraparib) on the NHS in England for women with advanced high-grade epithelial...